Straumann Holding AG (STMN):企業の財務・戦略的SWOT分析

◆英語タイトル:Straumann Holding AG (STMN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1606
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Straumann Holding AG (STMN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Straumann Holding AG (Straumann) is a provider of tooth replacement and orthodontic solutions. The company develops, manufactures and markets dental implants, instruments, digital equipment, CADCAM prosthetics, dental biomaterials, software and clear aligners for application in tooth replacement, restoration and prevention of tooth loss. It also provides training, support and other services to dental practitioners, clinics and laboratories. The company provides products and solutions for both conventional treatment and digital workflows including guided surgery and intra-oral scanning. The company distributes products, solutions and services directly and also through a network of partners in Europe, the Middle East and Africa, North America; Asia Pacific; and Latin America. Straumann is headquartered in Basel, Switzerland.

Straumann Holding AG Key Recent Developments

Feb 18,2020 Straumann finishes 2019 with solid Q4, as full-year organic revenue climbs 17% and core EBIT margin expands to 27.1%
Feb 03,2020 Mark Johnson joins Straumann’s Executive Management as Head of Research, Development & Operations, succeeding Dr Gerhard Bauer, who is retiring after a distinguished career with the Group
Dec 06,2019 Straumann Group strengthens emphasis on orthodontics and digital transformation
Aug 29,2019 Straumann Group announces two appointments to its Executive Management team

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Straumann Holding AG – Key Facts
Straumann Holding AG – Key Employees
Straumann Holding AG – Key Employee Biographies
Straumann Holding AG – Major Products and Services
Straumann Holding AG – History
Straumann Holding AG – Company Statement
Straumann Holding AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 – Company Analysis
Company Overview
Straumann Holding AG – Business Description
Business Segment: Implant Solutions
Overview
Performance
Business Segment: Other
Overview
Performance
Business Segment: Restorative Solutions
Overview
Performance
Geographical Segment: Asia Pacific
Target Markets
Performance
Geographical Segment: Europe, Middle East & Africa
Target Markets
Performance
Geographical Segment: LATAM
Target Markets
Performance
Geographical Segment: North America
Target Markets
Performance
Straumann Holding AG – Corporate Strategy
Straumann Holding AG – SWOT Analysis
SWOT Analysis – Overview
Straumann Holding AG – Strengths
Straumann Holding AG – Weaknesses
Straumann Holding AG – Opportunities
Straumann Holding AG – Threats
Straumann Holding AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Straumann Holding AG, Medical Equipment, Deals By Year, 2014 to YTD 2020
Straumann Holding AG, Medical Equipment, Deals By Type, 2014 to YTD 2020
Straumann Holding AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 18, 2020: Straumann finishes 2019 with solid Q4, as full-year organic revenue climbs 17% and core EBIT margin expands to 27.1%
Feb 03, 2020: Mark Johnson joins Straumann’s Executive Management as Head of Research, Development & Operations, succeeding Dr Gerhard Bauer, who is retiring after a distinguished career with the Group
Dec 06, 2019: Straumann Group strengthens emphasis on orthodontics and digital transformation
Aug 29, 2019: Straumann Group announces two appointments to its Executive Management team
Aug 14, 2019: Straumann Group: Strong momentum continues as first-half organic revenue climbs 16% and core EBIT margin reaches 28%
Apr 30, 2019: Promising start to the year with 17% organic growth in first quarter
Feb 19, 2019: Straumann posts strong Q4, lifting full-year organic revenue growth to 19% as underlying EBITDA margin reaches 30%
Jan 22, 2019: Straumann Group appoints Alastair Robertson as Head of Global People Management & Development
Jan 15, 2019: Straumann Group announces leadership succession plan
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Straumann Holding AG, Key Facts
Straumann Holding AG, Key Employees
Straumann Holding AG, Key Employee Biographies
Straumann Holding AG, Major Products and Services
Straumann Holding AG, History
Straumann Holding AG, Subsidiaries
Straumann Holding AG, Affiliate
Straumann Holding AG, Key Competitors
Straumann Holding AG, Ratios based on current share price
Straumann Holding AG, Annual Ratios
Straumann Holding AG, Annual Ratios (Cont...1)
Straumann Holding AG, Annual Ratios (Cont...2)
Straumann Holding AG, Interim Ratios
Straumann Holding AG, Medical Equipment, Deals By Year, 2014 to YTD 2020
Straumann Holding AG, Medical Equipment, Deals By Type, 2014 to YTD 2020
Straumann Holding AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Straumann Holding AG, Performance Chart (2015 - 2019)
Straumann Holding AG, Ratio Charts
Straumann Holding AG, Medical Equipment, Deals By Year, 2014 to YTD 2020
Straumann Holding AG, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Straumann Holding AG (STMN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Littelfuse, Inc.:企業のM&A・事業提携・投資動向
    Littelfuse, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Littelfuse, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • A&W Food Services of Canada Inc.:戦略・SWOT・企業財務分析
    A&W Food Services of Canada Inc. - Strategy, SWOT and Corporate Finance Report Summary A&W Food Services of Canada Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • TRACON Pharmaceuticals Inc (TCON):医療機器:M&Aディール及び事業提携情報
    Summary TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TRC253, TRC694, and TRC205. Its lead product …
  • Australian Leaders Fund Limited:企業の戦略・SWOT・財務情報
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Aditya Birla Retail Ltd:企業の戦略的SWOT分析
    Aditya Birla Retail Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Gedeon Richter Plc:企業のM&A・事業提携・投資動向
    Gedeon Richter Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gedeon Richter Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • BioClin Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioClin Therapeutics Inc (BioClin) is a clinical stage biotechnology company developing protein therapeutics for genetic disorders. Its lead product candidate B-701 is a human monoclonal antibody which targets the activity of FGFR3 (fibroblast growth factor receptor 3) and does not interact …
  • Calfrac Well Services Ltd. (CFW):企業の財務・戦略的SWOT分析
    Calfrac Well Services Ltd. (CFW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Oxford Biodynamics Plc:医療機器:M&Aディール及び事業提携情報
    Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neu …
  • Sykes Enterprises, Incorporated:企業の戦略・SWOT・財務情報
    Sykes Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Sykes Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • American Airlines Group Inc (AAL):企業の財務・戦略的SWOT分析
    American Airlines Group Inc (AAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Ping An Insurance (Group) Company of China, Ltd.:企業のM&A・事業提携・投資動向
    Ping An Insurance (Group) Company of China, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ping An Insurance (Group) Company of China, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • Norgine BV:医療機器:M&Aディール及び事業提携情報
    Summary Norgine BV (Norgine) is a pharmaceutical company that offers medicinal products. The company develops drugs in the therapeutic areas of gastroenterology, incontinence, hepatology and critical and supportive care and pain management, among others. It offers the treatment of diseases related t …
  • Avery Dennison Corporation (AVY):企業の財務・戦略的SWOT分析
    Avery Dennison Corporation (AVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Odakyu Electric Railway Co., Ltd. (9007):企業の財務・戦略的SWOT分析
    Odakyu Electric Railway Co., Ltd. (9007) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Formula Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Formula Pharmaceuticals Inc (Formula Pharmaceuticals) is a biopharmaceutical company that develops chimeric antigen receptor immunotherapy for oncology and autoimmune diseases. The company provides its pipeline products such as CIK-CAR.CD19, used as B-lymphocyte surface antigen; CIK-CAR.CD33 …
  • Virgin Media Inc:企業の戦略的SWOT分析
    Virgin Media Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Berry Global Group, Inc.:企業の戦略・SWOT・財務情報
    Berry Global Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Maastricht University:製薬・医療:M&Aディール及び事業提携情報
    Summary Maastricht University (MU) is an educational service provider that offers academic programs such as bachelor degree, master and doctoral programs. The university offers postgraduate research degrees in various subjects for a range of research needs and interests. It offers programs through i …
  • Votorantim SA:企業の戦略的SWOT分析
    Votorantim SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆